REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/10/2025
Back to search
Official data from USPTO
SIRACUSA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
03/10/2025
Trademark type
Word
Nice classes
5, 42
Filing date
04/20/2018
Registration date
03/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
03/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Wrexham, GB
Examiner
KHOURI, SANI
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ipsen Biopharm Limited
Representatives
Frances M. Jagla LANE POWELL PC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in oncologyendocrinologyneurologyhematologygastroenterologyfor cardiovascular and cognitive disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment and prevention of neuromuscular disordersmuscle disorders orthopedic disordersdisorders relating to age; pharmaceutical preparations for the treatment of painmuscle spasmhemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystoniatorticolliscerebral palsyspasticity; pharmaceutical preparations for the treatment of glabellar linesfacial wrinklesasymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxinbotulinum toxin-haemagglutin complexbotulinum toxin fragments and other derivatives for use in the treatment of excessive sweatingneuromuscular disordersmuscle disordersorthopedic disordersdisorders relating to agepainmuscle spasmhemifacial spasm and blepharospasmcervical dystoniatorticolliscerebral palsyspasticityglabellar linesfacial wrinklesasymmetries and defects and conditions of the human skin
Class 42
Conducting clinical trials for others for pharmaceuticals; research in the field of pharmaceuticals; scientific research for the purpose of medical evaluations; biologicalclinical and medical research; conducting clinical trials for others; providing information in medical and scientific research in the field of pharmaceutical products and clinical trials; conducting tests on pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2019
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2019
GNRT
NON-FINAL ACTION E-MAILED
05/05/2019
CNRT
NON-FINAL ACTION WRITTEN
05/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/15/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/15/2019
GNRT
NON-FINAL ACTION E-MAILED
03/15/2019
CNRT
NON-FINAL ACTION WRITTEN
03/15/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2019
ALIE
ASSIGNED TO LIE
02/19/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/13/2018
GNRT
NON-FINAL ACTION E-MAILED
08/13/2018
CNRT
NON-FINAL ACTION WRITTEN
08/13/2018
DOCK
ASSIGNED TO EXAMINER
08/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2018
NWAP
NEW APPLICATION ENTERED
04/24/2018
Continuous trademark protection
Get notified about every new filing that threatens SIRACUSA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.